171 related articles for article (PubMed ID: 19343359)
1. Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure.
Shimura M; Yasuda K; Nakazawa T; Shiono T; Sakamoto T; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):907-12. PubMed ID: 19343359
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Nishida K
Br J Ophthalmol; 2007 Apr; 91(4):449-54. PubMed ID: 17077114
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
[TBL] [Abstract][Full Text] [Related]
4. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
5. Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema.
Ozkurt YB; Akkaya S; Aksoy S; Evciman T; Haboğlu M
J Ocul Pharmacol Ther; 2015 Oct; 31(8):455-60. PubMed ID: 26154736
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
8. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Yang YH; Hsu WC; Hsieh YT
Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
10. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
Veritti D; Lanzetta P; Perissin L; Bandello F
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
[TBL] [Abstract][Full Text] [Related]
11. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
12. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
13. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497
[TBL] [Abstract][Full Text] [Related]
14. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Bakri SJ; Kaiser PK
Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy.
Shimonagano Y; Doi N; Noda Y; Uemura A; Sakamoto T
Jpn J Ophthalmol; 2007; 51(4):278-84. PubMed ID: 17660988
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].
Selim Kocabora M; Kucuksahin H; Gulkilik G; Taskapili M; Yilmazli C; Engin G
J Fr Ophtalmol; 2007 Jan; 30(1):32-8. PubMed ID: 17287669
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
18. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
[TBL] [Abstract][Full Text] [Related]
19. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]